Increased ESRP1 can enrich for CD44v; thus, consistent with the prognostic ability ofESRP1, higher levels of CD44v, but not high CD44s or total CD44 levels, areprognostic markers for distant metastases in lung and breast cancer.79 This evidence concerns the gene ESRP1 and breast carcinoma.